LXRX — Lexicon Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $406.29m
- $335.77m
- $1.20m
Annual cashflow statement for Lexicon Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 130 | -58.6 | -87.8 | -102 | -177 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 44.3 | -118 | 10.7 | 12.3 | 12 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -58.3 | 31.1 | -10.2 | 0.402 | 2.66 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 114 | -143 | -87 | -88.9 | -162 |
| Capital Expenditures | -0.07 | -0.087 | -1.22 | -1.33 | -0.47 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -156 | 381 | 3.33 | -69.8 | -49.5 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -156 | 381 | 2.11 | -71.1 | -49.9 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2.23 | -148 | 22.7 | 142 | 188 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -44.3 | 90.2 | -62.2 | -17.7 | -23.9 |